Cyteir Therapeutics, Inc.
(NASDAQ : CYT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Commercial Services » Miscellaneous Commercial Services
symbolcompany%chnglast%shortavg$volume
ETSYEtsy, Inc. -7.78%183.517.5%$425.34m
TALTAL Education Group 3.41%6.070.7%$335.89m
STMPStamps.com, Inc. 0.07%326.7624.0%$239.04m
BTBTBit Digital, Inc. 13.07%9.000.0%$207.24m
FLTFLEETCOR Technologies, Inc. -0.73%258.083.6%$176.65m
EFXEquifax, Inc. 0.09%260.852.0%$158.53m
CPRTCopart, Inc. 0.20%147.004.4%$125.64m
PAGSPagSeguro Digital Ltd. -2.17%55.410.0%$112.88m
CRLCharles River Laboratories International, Inc. 0.21%406.374.5%$103.83m
FOURShift4 Payments, Inc. -1.10%89.190.0%$97.85m
CHGGChegg, Inc. -1.39%88.6613.4%$76.37m
BRBroadridge Financial Solutions, Inc. 0.54%173.401.5%$75.21m
PPDPPD, Inc. -0.13%46.120.0%$74.44m
CLVTClarivate Plc 2.47%22.810.0%$72.64m
SYNHSyneos Health, Inc. 0.25%89.670.0%$58.10m

Company Profile

Cyteir Therapeutics, Inc. engages in the development of novel therapeutics and deoxyribonucleic acid repair and synthetic lethal therapies. It exploits the synthetic lethality of gain-of-function DNA-damaging genes and DNA repair inhibition, resulting in selective death among cells. The company was founded by Kevin Mills and Timothy Romberger in June 2012 and is headquartered in Lexington, MA.